To cure myeloma by fostering research, education and excellence in clinical care worldwide.
The International Myeloma Society (IMS) promotes education, research and clinical care globally by:
The goals of the International Myeloma Society are to facilitate improved knowledge and understanding of appropriate, personalized therapeutic strategies for assessing and caring for patients with multiple myeloma. The IMS has a fundamental interest in ensuring that its educational content is consistent with these goals.
IMS aims to promote research, education, clinical studies, and workshops to improve prevention, diagnosis, prognosis, and treatment of multiple myeloma and related disorders for patients worldwide. The International Myeloma Society is an organization that fosters scientific exchange and will be responsible for the final selection of the International Myeloma Workshops.
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.